Translarna FDA Approval Status
FDA Approved: No
Brand name: Translarna
Generic name: ataluren
Company: PTC Therapeutics, Inc.
Treatment for: Duchenne Muscular Dystrophy
Translarna (ataluren) is a protein restoration therapy in development for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).
Development timeline for Translarna
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.